Open access · CC-BY
via OpenAlex
Editorial: Senescence and reprogramming: hallmarks in aging and disease
Francisco Javier González-Rico, Jiyue Zhu, Guangyong Peng
Frontiers in Cell and Developmental Biology · 2025
Genomic instability
Telomere attrition
Epigenetic alterations
Loss of proteostasis
Mitochondrial dysfunction
Cellular senescence
Altered intercellular communication
Chronic inflammation
Partial reprogramming (OSK)
Abstract
Phenotype (SASP) (Campisi and d'Adda di 2007). A key driver of celular senesence is the progressive shortening of telomeres that occurs with aging. Additionally, cells can enter senescence(definition) in response to various stressprs, including sustained mitogenic signaling, oncogene activation, DNA damage from irradiation, oxidative and genotoxic stress, epigenetic alterations, chromatin disorganization, perturbed proteostasis(definition), mitochondrial dysfunction(definition), inflammation signals, tissue damage, chemotherapeutic agents, and nutrient deprivation (Kumari and Jat, 2021).Both cellular senescence and organismal aging are closely conected to epigenetic states.During development, epigenetic modifications, including DNA methylation, histone modifications, and chromatin remodeling, collectively determine cellular differentiation status and cell fates. These differentiation states can also be reversed through the transcriptional and/or epigentic reprogramming of the cell. In cell reprogramming, the cell identity and plasticity can be altered by the overexpression of transcription factors such as Oct4, Sox2, Klf4 and c-Myc (OSKM) (Takahashi and Yamanaka, 2006). This induction creates a dedifferentiation state that enhances tissue regeneration and has been succesfully applied in various pathological contexts, including diabetes, muscle injuries, retinal degeneration, and myocardial infartion (Ocampo et al., 2016;Lu et al., 2020;Chen et al., 2021). Those We hope that the articles featured in this research topic will serve as valuable resources for researchers in the fields of aging, senescence, and cell reprogramming, whether they are well-established experts or newcomers eager to explore this exciting arena.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fcell.2025.1622682
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
González-Rico, F.J., Zhu, J., & Peng, G. (2025). Editorial: Senescence and reprogramming: hallmarks in aging and disease. <em>Frontiers in Cell and Developmental Biology</em>. https://doi.org/10.3389/fcell.2025.1622682
Vancouver
González-Rico FJ, Zhu J, Peng G. Editorial: Senescence and reprogramming: hallmarks in aging and disease. Frontiers in Cell and Developmental Biology. 2025. doi:10.3389/fcell.2025.1622682.
BibTeX
@article{francisco2025Editor,
title = {Editorial: Senescence and reprogramming: hallmarks in aging and disease},
author = {Francisco Javier González-Rico and Jiyue Zhu and Guangyong Peng},
journal = {Frontiers in Cell and Developmental Biology},
year = {2025},
doi = {10.3389/fcell.2025.1622682},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Elsevier eBooks 2026
Citation only
Reprogramming a cell's epigenetic status for reverse aging
Ageing and Cancer Research & Treatment 2024
Open access · CC-BY
Protein post-translational modifications in aging and cancer: Mechanisms and translational implications
Biochemia Medica 2019
Open access · CC-BY
Hallmarks of senescence and aging
Experimental Cell Research 2021
Open access · CC-BY
Balancing DNA repair to prevent ageing and cancer
Shengming kexue 2026
Open access · OA
Cellular senescence and senescence-associated secretory phenotypes
Progress in molecular biology and translational science 2023
Citation only